Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs Etsy Inc (ETSY) Price & Performance

Quest Diagnostics IncTrade
Etsy IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs Etsy Inc — how do they compare? Quest Diagnostics Inc trades at $202.3 (market cap $22.80B), while Etsy Inc trades at $83.37 (market cap $7.88B). The key difference: Quest Diagnostics Inc is far larger — about 2.9× Etsy Inc's market cap, and Quest Diagnostics Inc pays a 1.67% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.

DGXETSY
Market Cap
$22.80B$7.88B
Sector
HealthConsumer Cyclical
52-Week High
$216.02$85.74
52-Week Low
$166.45$44.05
Enterprise Value
$28.82B$9.53B
Dividend Yield
1.67%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.

DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.

Etsy Inc

ETSY trades at $80.53, down 0.64% today, with strong technical momentum as the stock has rallied 40% over the past three months. The company shows mixed fundamentals with revenue stabilizing around $2.9B but net income declining to $163M in 2025. Recent earnings beats and positive analyst sentiment (48.9% buy ratings) support the bullish technical outlook, though valuation metrics remain elevated with a P/E of 30.85.

The outlook remains cautiously optimistic with AI-driven marketplace improvements and seller tools driving growth potential. Key risks include active buyer declines, competitive pressures from larger e-commerce players, and high debt levels. The stock trades near analyst consensus targets, suggesting limited near-term upside from current levels despite positive momentum indicators.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About Etsy Inc

Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).

Read more on ETSY